Gufic Biosciences receives TGA Australia and ANVISA Brazil approval for Parecoxib 40mg injection
Parecoxib Sodium is the first parenteral selective COX-2 inhibitor available for clinical use in pain management
Parecoxib Sodium is the first parenteral selective COX-2 inhibitor available for clinical use in pain management
The company will develop and produce premixes for human nutrition applications
Biocon Biologics recently acquired the global biosimilars business of its long-term partner Viatris
These plant locations include Ramagundam, Talcher Kaniha, Korba, Vindhyachal, Dadri, Barh, Solapur, North Karanpura, and Mauda
This indigenously developed enhanced care technology is designed to continuously monitor and detect early signs of deterioration in a patient's condition
The cognitively operated system is a mother patent invention, first launched in India
Amgen will be prohibited from leveraging its drug portfolio to disadvantage rivals and will be required to seek prior approval before acquiring related products
Health Assurance is a unique healthcare model that combines health insurance with preventive healthcare with a focus on keeping people healthy while providing sick care for them when needed
Sets price band at ?695 to ?735 per Equity Share
The facility has a potential for capacity expansion up to 2 billion tablets/capsules per year
Subscribe To Our Newsletter & Stay Updated